| The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells D Mougiakakos, R Jitschin, CC Johansson, R Okita, R Kiessling, ... Blood, The Journal of the American Society of Hematology 117 (18), 4826-4835, 2011 | 268 | 2011 |
| CD4+ CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer R Okita, T Saeki, S Takashima, Y Yamaguchi, T Toge Oncology reports 14 (5), 1269-1273, 2005 | 149 | 2005 |
| PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer R Okita, A Maeda, K Shimizu, Y Nojima, S Saisho, M Nakata Cancer Immunology, Immunotherapy 66, 865-876, 2017 | 148 | 2017 |
| Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata World journal of surgical oncology 13, 1-8, 2015 | 115 | 2015 |
| HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines R Okita, D Mougiakakos, T Ando, Y Mao, D Sarhan, E Wennerberg, ... The Journal of Immunology 188 (5), 2136-2145, 2012 | 73 | 2012 |
| MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer R Okita, T Yukawa, Y Nojima, A Maeda, S Saisho, K Shimizu, M Nakata Cancer Immunology, Immunotherapy 65, 499-509, 2016 | 67 | 2016 |
| Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy S Saisho, K Yasuda, A Maeda, T Yukawa, R Okita, Y Hirami, K Shimizu, ... Interactive cardiovascular and thoracic surgery 16 (2), 166-172, 2013 | 65 | 2013 |
| T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2 K Mimura, T Ando, I Poschke, D Mougiakakos, CC Johansson, J Ichikawa, ... International journal of cancer 128 (2), 390-401, 2011 | 60 | 2011 |
| Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy R Okita, M Yamashita, M Nakata, N Teramoto, A Bessho, H Mogami The Annals of Thoracic Surgery 79 (1), e1-e2, 2005 | 48 | 2005 |
| Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata OncoTargets and therapy, 153-163, 2016 | 39 | 2016 |
| Contrasting effects of the cytotoxic anticancer drug gemcitabine and the EGFR tyrosine kinase inhibitor gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D … R Okita, D Wolf, K Yasuda, A Maeda, T Yukawa, S Saisho, K Shimizu, ... PLoS One 10 (10), e0139809, 2015 | 37 | 2015 |
| Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer K Shimizu, R Okita, S Saisho, T Yukawa, A Maeda, Y Nojima, M Nakata Annals of Nuclear Medicine 29, 854-860, 2015 | 36 | 2015 |
| Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis A Maeda, M Nakata, K Yasuda, T Yukawa, S Saisho, R Okita, Y Hirami, ... Oncology reports 29 (1), 39-44, 2013 | 36 | 2013 |
| FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients K Matsuura, Y Yamaguchi, A Osaki, M Ohara, R Okita, A Emi, S Murakami, ... Oncology reports 22 (5), 1181-1187, 2009 | 36 | 2009 |
| Targeting of CD4+ CD25high cells while preserving CD4+ CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer R Okita, Y Yamaguchi, M Ohara, K Hironaka, M Okawaki, I Nagamine, ... International journal of oncology 34 (2), 563-572, 2009 | 34 | 2009 |
| Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory … Y Yamaguchi, J Hihara, K Hironaka, A Ohshita, R Okita, M Okawaki, ... Oncology reports 15 (4), 895-901, 2006 | 32 | 2006 |
| Successful surgical treatment of aortoesophageal fistula after esophagectomy R Okita, H Mukaida, W Takiyama, M Oheda, N Uchida, H Ishihara The Annals of thoracic surgery 79 (3), 1059-1061, 2005 | 32 | 2005 |
| Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small … K Shimizu, T Yukawa, Y Hirami, R Okita, S Saisho, A Maeda, K Yasuda, ... Targeted oncology 8, 237-242, 2013 | 31 | 2013 |
| High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis D Mougiakakos, R Okita, T Ando, C Dürr, J Gadiot, J Ichikawa, R Zeiser, ... Journal of molecular medicine 90, 935-944, 2012 | 30 | 2012 |
| Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells Y Yamaguchi, K Ohta, Y Kawabuchi, A Ohshita, R Okita, M Okawaki, ... Anticancer research 25 (3C), 2407-2415, 2005 | 29 | 2005 |
